CD8A and viral infectious disease: Although rapamycin inhibition of mTOR has been reported to impair the differentiation of effector CD8+ T-cells, lead to loss of function, failure to control viral infections and cellular anergy (Araki et al., 2010; Yao et al., 2013; Goldberg et al., 2014), this was not observed in this study.